Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_403f881177f7ee7023114f76bef55a32 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164 |
filingDate |
2017-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30748e24315c4ff25ef69f326323359e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a952270625ac3280c32e8270056c0d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9483ced7c8027506e5ab293c75e3e90 |
publicationDate |
2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018303776-A1 |
titleOfInvention |
Liposomal rehydration salt formulation for treatment of alcohol related disorders |
abstract |
A liposomal rehydration salt formulation includes phospholipids at a concentration of about 1.0 g/L to 10.0 g/L, salts, water, oleoylethanolamide, and a percentage inclusion ratio of salts (salts retained within total salts/liposomes) of at least 50% and a sodium electrolyte of about 12 mEq/L to 90 mEq/L. The formulation has an actual osmolarity lower than 130 based on the at least 50% encapsulation of the salts and the liposomes comprise a particle diameter ranging from 200 nm to 500 nm. |
priorityDate |
2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |